World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 79 17621 16563 8804 8137 265 21528

Michael A. Nalesnik publications per year

The chart shows the history of publications by Michael A. Nalesnik between 1982 and 2024, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Michael A. Nalesnik published across 43 years, from 1982 to 2024, averaging 6.5 papers a year. Output peaked at 16 publications in 2008. 3 of the 278 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1982 to 2024. Vertical axis: number of publications, 0 to 16. Peak 16 publications in 2008. 1982: 1 publication 1983: 1 publication 1984: 2 publications 1985: 1 publication 1986: 2 publications 1987: 2 publications 1988: 3 publications 1989: 3 publications 1990: 6 publications 1991: 11 publications 1992: 8 publications 1993: 8 publications 1994: 10 publications 1995: 14 publications 1996: 12 publications 1997: 11 publications 1998: 7 publications 1999: 9 publications 2000: 10 publications 2001: 12 publications 2002: 8 publications 2003: 11 publications 2004: 13 publications 2005: 5 publications 2006: 15 publications 2007: 5 publications 2008: 16 publications 2009: 9 publications 2010: 7 publications 2011: 7 publications 2012: 4 publications 2013: 3 publications 2014: 3 publications 2015: 6 publications 2016: 3 publications 2017: 3 publications 2018: 5 publications 2019: 3 publications 2020: 7 publications 2021: 8 publications 2022: 1 publication 2023: 1 publication 2024: 2 publications
1982 2024

278 publications in total across all disciplines

View publications per year as a table
Michael A. Nalesnik: publications per year, 1982 to 2024
Year Publications
1982 1
1983 1
1984 2
1985 1
1986 2
1987 2
1988 3
1989 3
1990 6
1991 11
1992 8
1993 8
1994 10
1995 14
1996 12
1997 11
1998 7
1999 9
2000 10
2001 12
2002 8
2003 11
2004 13
2005 5
2006 15
2007 5
2008 16
2009 9
2010 7
2011 7
2012 4
2013 3
2014 3
2015 6
2016 3
2017 3
2018 5
2019 3
2020 7
2021 8
2022 1
2023 1
2024 2
Total 278
Download as CSV

Michael A. Nalesnik publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael A. Nalesnik sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 261–280 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 265 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722 265
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Michael A. Nalesnik D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael A. Nalesnik sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 78–79 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891 79
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Michael A. Nalesnik is affiliated with the University of Pittsburgh in the United States. Their research focuses primarily on medicine, with significant contributions in epidemiology, oncology, hepatology, pulmonary and respiratory medicine, and molecular biology.

The scientist has concentrated on several key topics throughout their career. These include:

  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Renal Transplantation Outcomes and Treatments
  • Neuroblastoma Research and Treatments

Recent publications by Michael A. Nalesnik highlight diverse areas of medical research and transplantation science. Notable papers include:

  • Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size, 2021, published in Gut
  • Ten years of donor-derived disease: A report of the disease transmission advisory committee, 2020, American Journal of Transplantation
  • Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant Patients, 2021, Hepatology Communications
  • Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings, 2020, Oncogene
  • Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee, 2020, Transplant Infectious Disease

They have coauthored multiple works with several frequent collaborators, including:

  • Aatur D. Singhi
  • Silvia Liu
  • Bao-Guo Ren
  • George K. Michalopoulos
  • Marc G. Ghany

Michael A. Nalesnik's work is published in a variety of scientific journals, with multiple papers appearing in:

  • Hepatology Communications
  • UNC Libraries
  • Gastroenterology
  • Gut
  • American Journal of Transplantation

The scope of their research addresses complex issues in liver transplant outcomes, disease transmission, cancer biology, and viral hepatitis, providing insights across several interconnected disciplines within medicine.

Best Publications

  • Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

    C L Nastala;H D Edington;T G McKinney;H Tahara

  • Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance

    Thomas E. Starzl;Anthony J. Demetris;Massimo Trucco;Noriko Murase

  • The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

    M A Nalesnik;R Jaffe;T E Starzl;A J Demetris

  • The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

    Elsie S. Lee;Joseph Locker;Michael Nalesnik;Jorge Reyes

  • Epstein-barr virus-induced posttransplant lymphoproliferative disorders

    Carlos V. Paya;John J. Fung;Michael A. Nalesnik;Elliott Kieff

  • Tolerogenic immunosuppression for organ transplantation.

    Thomas E Starzl;Noriko Murase;Kareem Abu-Elmagd;Edward A Gray

  • THE FREQUENCY OF EPSTEIN-BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN

    Monto Ho;Ronald Jaffe;George Miller;Mary Kay Breinig

  • Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT.

    R L Baron;J H Oliver rd;G D Dodd rd;M Nalesnik

  • Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.

    Armitage Jm;Kormos Rl;Stuart Rs;Fricker Fj

  • Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: A distinct entity?

    Beverly P. Nelson;Michael A. Nalesnik;David W. Bahler;Joseph Locker

  • Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.

    Elizabeth A. Pomfret;Kenneth Washburn;Christoph Wald;Michael A. Nalesnik

  • Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.

    Masahiro Shuda;Reety Arora;Hyun Jin Kwun;Huichen Feng

  • Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas

    Jian-Hua Luo;Baoguo Ren;Sergei Keryanov;George C. Tseng

  • The diagnosis and treatment of posttransplant lymphoproliferative disorders.

    Michael A. Nalesnik;Leonard Makowka;Thomas E. Starzl;Thomas E. Starzl

  • Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors.

    Anne E. Wennerberg;Michael A. Nalesnik;William B. Coleman

  • Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience.

    Ashok Jain;Mike Nalesnik;Jorge Reyes;Renu Pokharna

  • Fibrolamellar Hepatocellular Carcinoma: Imaging and Pathologic Findings in 31 Recent Cases

    Tomoaki Ichikawa;Michael P. Federle;Luigi Grazioli;Juan Madariaga

  • Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury.

    Atsunori Nakao;Kei Kimizuka;Donna B. Stolz;Joao Seda Neto

  • Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.

    Parmjeet S. Randhawa;Ronald Jaffe;Anthony J. Demetris;Michael Nalesnik

  • An Update on Donor-Derived Disease Transmission in Organ Transplantation

    M. G. Ison;M. A. Nalesnik

Frequent Co-Authors

Anthony J. Demetris
Anthony J. Demetris University of Pittsburgh
Thomas E. Starzl
Thomas E. Starzl University of Pittsburgh
Noriko Murase
Noriko Murase University of Pittsburgh
Parmjeet Randhawa
Parmjeet Randhawa University of Pittsburgh
John J. Fung
John J. Fung University of Chicago
George K. Michalopoulos
George K. Michalopoulos University of Pittsburgh
David A. Geller
David A. Geller University of Pittsburgh
Kareem Abu-Elmagd
Kareem Abu-Elmagd Cleveland Clinic
Tong Wu
Tong Wu Chinese Academy of Sciences
Donna B. Stolz
Donna B. Stolz University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a career in healthcare but not ready to enroll in a traditional medical program, there are flexible alternative pathways available online. For example, online BSN programs for non nurses allow individuals with a degree in another field to pursue nursing without starting from scratch. These programs can help you transition into a meaningful healthcare career quickly.

If you prefer an administrative role, consider enrolling in an online BSN programs for non nurses offer a streamlined route into nursing, while accredited medical billing and coding schools online with financial aid provide a pathway to essential non-clinical roles, often with financial support available to qualifying students.

Some students may prefer an easier admissions process. There are nursing schools that don't require TEAS or HESI, so you can focus on your passion for nursing without test anxiety. Those interested in leadership and management roles in healthcare should look into accelerated healthcare administration degree programs, which can fast-track your entry into this dynamic field.

Best Scientists Citing Michael A. Nalesnik

Trending Scientists

Recently Published Articles